Document is current
Any future updates will be listed below
-
Authors
Gerardo, Charles J
Carter, Rebecca W
Kumar, Surendra
Shirazi, Farshad M
Kotehal, Suneetha D
Akpunonu, Peter D
Bhalla, Ashish
Schwartz, Richard B
Bammigatti, Chanaveerappa
Manikath, Neeraj
Mukherjee, Partha P
Arnold, Thomas C
Wolk, Brian J
S Sheikh, Sophia https://orcid.org/0000-0003-1939-3126
Sollee, Dawn R
Vearrier, David J
Francis, Samuel J
Aizenberg, Adiel
Kumar, Harish
Ravikumar, Madhu K
Sarkar, Sujoy
Haston, Taylor
Micciche, Andrew
Oomman, Suraj C https://orcid.org/0009-0000-5879-1886
Owen, Jeffery L
Ritter, Brandi A
Samuel, Stephen P
Lewin, Matthew R
Platts-Mills, Timothy F
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04996264 at ClinicalTrials.govDocuments that mention this clinical trial
Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trial
https://doi.org/10.1136/bmjgh-2024-015985
-
Funding
Funding for this research was provided by:
Defense Health Agency (W81XWH20C0017)
Wellcome Trust (222964/Z/21/Z)
- License Information
